Tag: health economics
The Patent Cliff: How Generic Drugs Reshape Brand Manufacturer Economics
Explore how generic drugs trigger the 'patent cliff' for brand manufacturers, reshaping pharmaceutical economics. Learn about Hatch-Waxman, pay-for-delay tactics, and the $330B in annual savings driving industry change.
Cost-Effectiveness Analysis: Measuring the Value of Generic Drugs
Cost-effectiveness analysis reveals how generic drugs save billions by comparing price to health outcomes. Learn why some generics cost more than others-and how switching can cut drug spending by up to 90%.
